Search results
Results from the WOW.Com Content Network
n/a Ensembl ENSG00000181143 n/a UniProt Q8WXI7 n/a RefSeq (mRNA) NM_024690 NM_001401501 n/a RefSeq (protein) NP_078966 n/a Location (UCSC) Chr 19: 8.85 – 8.98 Mb n/a PubMed search n/a Wikidata View/Edit Human Mucin-16 (MUC-16) also known as Ovarian cancer-related tumor marker CA125 is a protein that in humans is encoded by the MUC16 gene. MUC-16 is a member of the mucin family glycoproteins ...
CA-125 levels are not accurate in early stage ovarian cancer, as half of stage I ovarian cancer patients have a normal CA-125 level. [ 31 ] [ 29 ] CA-125 may also be elevated in benign (non-cancerous) conditions, including endometriosis , pregnancy , uterine fibroids , menstruation , ovarian cysts , systemic lupus erythematosus , liver disease ...
An ideal tumor marker does not exist, and how they are clinically applied depends on the specific tumor marker. For example, tumor markers like Ki-67 can be used to choose form of treatment or in prognostics but are not useful to give a diagnosis, while other tumor markers have the opposite functionality. Therefore it's important to follow the ...
Hypercalcemia, also spelled hypercalcaemia, is a high calcium (Ca 2+) level in the blood serum. [1] [3] The normal range for total calcium is 2.1–2.6 ...
The tumor marker CA-125 is frequently elevated in endometrial cancer and can be used to monitor response to treatment, particularly in serous cell cancer or advanced disease. [ 32 ] [ 44 ] [ 82 ] Periodic MRIs or CT scans may be recommended in advanced disease and women with a history of endometrial cancer should receive more frequent pelvic ...
High-grade serous carcinoma (HGSC) is a type of tumour that arises from the serous epithelial layer in the abdominopelvic cavity and is mainly found in the ovary. HGSCs make up the majority of ovarian cancer cases [ 1 ] and have the lowest survival rates. [ 2 ]
Close monitoring is advised for women who were treated with conservative surgery because of the high rate of relapse. [4] Follow-up visits should include clinical exploration, transvaginal ultrasound, and Ca125 levels, even though some authors have suggested adding Ca19.9 since it appears that some mucinous tumours do not mark Ca125.
The one biomarker that has been in use over the last 20 years is CA-125. [121] A 2016 review found that this biomarker was present in those with symptoms of endometriosis; and, once ovarian cancer has been ruled out, a positive CA-125 may confirm the diagnosis. [122] Its performance in ruling out endometriosis is low. [122]